Radioactive injection tested as last hope for tough cancers
NCT ID NCT07229768
Summary
This early-stage study is testing a new radioactive drug injection (177Lu-CTR-FAPI) for people with advanced cancers that have spread and no longer respond to standard treatments, focusing on pancreatic cancer. The main goals are to check if the treatment is safe, measure how much radiation reaches the tumor, and see if it helps shrink the cancer. It is a small, first-look study to gather initial information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.